350 related articles for article (PubMed ID: 23918374)
21. XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.
Semenchenko K; Wasylyk C; Cheung H; Tourrette Y; Maas P; Schalken JA; van der Pluijm G; Wasylyk B
PLoS One; 2016; 11(7):e0159531. PubMed ID: 27427904
[TBL] [Abstract][Full Text] [Related]
22. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
[TBL] [Abstract][Full Text] [Related]
23. RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.
Fang B
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):27-38. PubMed ID: 26350096
[TBL] [Abstract][Full Text] [Related]
24. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.
Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
[TBL] [Abstract][Full Text] [Related]
26. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
27. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.
Ichise T; Yoshida N; Ichise H
PLoS One; 2012; 7(12):e51639. PubMed ID: 23284731
[TBL] [Abstract][Full Text] [Related]
28. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.
Keld R; Guo B; Downey P; Gulmann C; Ang YS; Sharrocks AD
Mol Cancer; 2010 Dec; 9():313. PubMed ID: 21143918
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.
Hollenhorst PC; Ferris MW; Hull MA; Chae H; Kim S; Graves BJ
Genes Dev; 2011 Oct; 25(20):2147-57. PubMed ID: 22012618
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.
Torres A; Alshalalfa M; Tomlins SA; Erho N; Gibb EA; Chelliserry J; Lim L; Lam LLC; Faraj SF; Bezerra SM; Davicioni E; Yousefi K; Ross AE; Netto GJ; Schaeffer EM; Lotan TL
J Mol Diagn; 2017 May; 19(3):475-484. PubMed ID: 28341589
[TBL] [Abstract][Full Text] [Related]
32. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.
Ouyang X; Jessen WJ; Al-Ahmadie H; Serio AM; Lin Y; Shih WJ; Reuter VE; Scardino PT; Shen MM; Aronow BJ; Vickers AJ; Gerald WL; Abate-Shen C
Cancer Res; 2008 Apr; 68(7):2132-44. PubMed ID: 18381418
[TBL] [Abstract][Full Text] [Related]
33. Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression.
Alder D; Braun M; Nikolov P; Boehm D; Scheble V; Menon R; Fend F; Kristiansen G; Perner S; Wernert N
Hum Pathol; 2012 Nov; 43(11):1910-6. PubMed ID: 22569213
[TBL] [Abstract][Full Text] [Related]
34. COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM
Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435
[TBL] [Abstract][Full Text] [Related]
35. Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.
Kunju LP; Carskadon S; Siddiqui J; Tomlins SA; Chinnaiyan AM; Palanisamy N
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):e32-40. PubMed ID: 25203299
[TBL] [Abstract][Full Text] [Related]
36. An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression.
Zhang J; Wang Q; Qi S; Duan Y; Liu Z; Liu J; Zhang Z; Li C
J Transl Med; 2024 Jun; 22(1):547. PubMed ID: 38849954
[TBL] [Abstract][Full Text] [Related]
37. Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation.
Fung TM; Ng KY; Tong M; Chen JN; Chai S; Chan KT; Law S; Lee NP; Choi MY; Li B; Cheung AL; Tsao SW; Qin YR; Guan XY; Chan KW; Ma S
J Pathol; 2016 Jul; 239(3):309-19. PubMed ID: 27063000
[TBL] [Abstract][Full Text] [Related]
38. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
[TBL] [Abstract][Full Text] [Related]
39. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
[TBL] [Abstract][Full Text] [Related]
40. ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.
Tyagi N; Deshmukh SK; Srivastava SK; Azim S; Ahmad A; Al-Ghadhban A; Singh AP; Carter JE; Wang B; Singh S
Mol Cancer Res; 2018 Feb; 16(2):187-196. PubMed ID: 29117940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
